2022 ICD-10-CM Code E71.0
Maple-syrup-urine disease
Code Classification
E71.0 is a billable diagnosis code used to specify a medical diagnosis of maple-syrup-urine disease. The code E71.0 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code E71.0 might also be used to specify conditions or terms like classical maple syrup urine disease, dihydrolipoamide dehydrogenase deficiency, intermediate maple syrup urine disease, intermittent maple syrup urine disease, maple syrup urine disease , maple syrup urine disease, multiple dehydrogenase form, etc.
Entries in the Index to Diseases and Injuries with references to E71.0
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code E71.0 are found in the index:
- - Disease, diseased - See Also: Syndrome;
- - maple-syrup-urine - E71.0
- - Disorder (of) - See Also: Disease;
- - metabolism NOS - E88.9
- - amino-acid - E72.9
- - branched chain - E71.2
- - maple syrup urine disease - E71.0
- - branched chain - E71.2
- - amino-acid - E72.9
- - metabolism NOS - E88.9
- - Maple-syrup-urine disease - E71.0
- - Syndrome - See Also: Disease;
- - maple-syrup-urine - E71.0
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Classical maple syrup urine disease
- Dihydrolipoamide dehydrogenase deficiency
- Intermediate maple syrup urine disease
- Intermittent maple syrup urine disease
- Maple syrup urine disease
- Maple syrup urine disease, multiple dehydrogenase form
- Mild maple syrup urine disease
- Thiamin-responsive maple syrup urine disease
Clinical Information
- MAPLE SYRUP URINE DISEASE-. an autosomal recessive inherited disorder with multiple forms of phenotypic expression caused by a defect in the oxidative decarboxylation of branched chain amino acids amino acids branched chain. these metabolites accumulate in body fluids and render a "maple syrup" odor. the disease is divided into classic intermediate intermittent and thiamine responsive subtypes. the classic form presents in the first week of life with ketoacidosis hypoglycemia emesis neonatal seizures and hypertonia. the intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. from adams et al. principles of neurology 6th ed p936
Convert E71.0 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code E71.0 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 270.3 - Bran-chain amin-acid dis (Approximate Flag)
Information for Patients
Metabolic Disorders
Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system break the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body tissues, such as your liver, muscles, and body fat.
A metabolic disorder occurs when abnormal chemical reactions in your body disrupt this process. When this happens, you might have too much of some substances or too little of other ones that you need to stay healthy. There are different groups of disorders. Some affect the breakdown of amino acids, carbohydrates, or lipids. Another group, mitochondrial diseases, affects the parts of the cells that produce the energy.
You can develop a metabolic disorder when some organs, such as your liver or pancreas, become diseased or do not function normally. Diabetes is an example.
[Learn More in MedlinePlus]
Maple syrup urine disease
Maple syrup urine disease is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. The condition gets its name from the distinctive sweet odor of affected infants' urine. It is also characterized by poor feeding, vomiting, lack of energy (lethargy), abnormal movements, and delayed development. If untreated, maple syrup urine disease can lead to seizures, coma, and death.
Maple syrup urine disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still lead to delayed development and other health problems if not treated.
[Learn More in MedlinePlus]
Related Codes
ICD Code | Description | Valid for Submission |
---|---|---|
E71 | Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism | NON-BILLABLE CODE |
E71.1 | Other disorders of branched-chain amino-acid metabolism | NON-BILLABLE CODE |
E71.11 | Branched-chain organic acidurias | NON-BILLABLE CODE |
E71.110 | Isovaleric acidemia | BILLABLE CODE |
E71.111 | 3-methylglutaconic aciduria | BILLABLE CODE |
E71.118 | Other branched-chain organic acidurias | BILLABLE CODE |
E71.12 | Disorders of propionate metabolism | NON-BILLABLE CODE |
E71.120 | Methylmalonic acidemia | BILLABLE CODE |
E71.121 | Propionic acidemia | BILLABLE CODE |
E71.128 | Other disorders of propionate metabolism | BILLABLE CODE |
E71.19 | Other disorders of branched-chain amino-acid metabolism | BILLABLE CODE |
E71.2 | Disorder of branched-chain amino-acid metabolism, unspecified | BILLABLE CODE |
E71.3 | Disorders of fatty-acid metabolism | NON-BILLABLE CODE |
E71.30 | Disorder of fatty-acid metabolism, unspecified | BILLABLE CODE |
E71.31 | Disorders of fatty-acid oxidation | NON-BILLABLE CODE |
E71.310 | Long chain/very long chain acyl CoA dehydrogenase deficiency | BILLABLE CODE |
E71.311 | Medium chain acyl CoA dehydrogenase deficiency | BILLABLE CODE |
E71.312 | Short chain acyl CoA dehydrogenase deficiency | BILLABLE CODE |
E71.313 | Glutaric aciduria type II | BILLABLE CODE |
E71.314 | Muscle carnitine palmitoyltransferase deficiency | BILLABLE CODE |
E71.318 | Other disorders of fatty-acid oxidation | BILLABLE CODE |
E71.32 | Disorders of ketone metabolism | BILLABLE CODE |
E71.39 | Other disorders of fatty-acid metabolism | BILLABLE CODE |
E71.4 | Disorders of carnitine metabolism | NON-BILLABLE CODE |
E71.40 | Disorder of carnitine metabolism, unspecified | BILLABLE CODE |
E71.41 | Primary carnitine deficiency | BILLABLE CODE |
E71.42 | Carnitine deficiency due to inborn errors of metabolism | BILLABLE CODE |
E71.43 | Iatrogenic carnitine deficiency | BILLABLE CODE |
E71.44 | Other secondary carnitine deficiency | NON-BILLABLE CODE |
E71.440 | Ruvalcaba-Myhre-Smith syndrome | BILLABLE CODE |
E71.448 | Other secondary carnitine deficiency | BILLABLE CODE |
E71.5 | Peroxisomal disorders | NON-BILLABLE CODE |
E71.50 | Peroxisomal disorder, unspecified | BILLABLE CODE |
E71.51 | Disorders of peroxisome biogenesis | NON-BILLABLE CODE |
E71.510 | Zellweger syndrome | BILLABLE CODE |
E71.511 | Neonatal adrenoleukodystrophy | BILLABLE CODE |
E71.518 | Other disorders of peroxisome biogenesis | BILLABLE CODE |
E71.52 | X-linked adrenoleukodystrophy | NON-BILLABLE CODE |
E71.520 | Childhood cerebral X-linked adrenoleukodystrophy | BILLABLE CODE |
E71.521 | Adolescent X-linked adrenoleukodystrophy | BILLABLE CODE |
E71.522 | Adrenomyeloneuropathy | BILLABLE CODE |
E71.528 | Other X-linked adrenoleukodystrophy | BILLABLE CODE |
E71.529 | X-linked adrenoleukodystrophy, unspecified type | BILLABLE CODE |
E71.53 | Other group 2 peroxisomal disorders | BILLABLE CODE |
E71.54 | Other peroxisomal disorders | NON-BILLABLE CODE |
E71.540 | Rhizomelic chondrodysplasia punctata | BILLABLE CODE |
E71.541 | Zellweger-like syndrome | BILLABLE CODE |
E71.542 | Other group 3 peroxisomal disorders | BILLABLE CODE |
E71.548 | Other peroxisomal disorders | BILLABLE CODE |
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)